Onconova Announces Ten Presentations at the 2014 ASH Annual Meeting
November 06, 2014 09:26 ET
|
Onconova Therapeutics
--Phase 3 ONTIME Trial Data Selected for Oral Presentation--
--Data from Phase 1/2 Trial of Oral Rigosertib and Azacitidine Combination Highlighted--
NEWTOWN, Pa., Nov. 6, 2014 (GLOBE...
Onconova Therapeutics, Inc. to Present at Rodman & Renshaw 16th Annual Global Investment Conference
September 03, 2014 07:01 ET
|
Onconova Therapeutics
NEWTOWN, Pa., Sept. 3, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. Reports Second Quarter 2014 Financial and Operational Results
August 13, 2014 16:01 ET
|
Onconova Therapeutics
NEWTOWN, Pa., Aug. 13, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. Announces Timing for Second Quarter 2014 Financial Results and Conference Call
August 06, 2014 08:57 ET
|
Onconova Therapeutics
NEWTOWN, Pa., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. Reports First Quarter 2014 Financial and Operational Results
May 12, 2014 16:01 ET
|
Onconova Therapeutics
NEWTOWN, Pa., May 12, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. Announces Timing for First Quarter 2014 Financial Results and Conference Call
May 06, 2014 08:58 ET
|
Onconova Therapeutics
NEWTOWN, Pa., May 6, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Development Programs Highlighted in Seven Presentations at AACR Annual Meeting
April 07, 2014 09:33 ET
|
Onconova Therapeutics
NEWTOWN, Pa., April 7, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. Reports Fourth Quarter and Year-End 2013 Financial Results and Outlines Key Objectives for 2014
March 10, 2014 16:01 ET
|
Onconova Therapeutics
NEWTOWN, Pa., March 10, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. Announces Timing for Fourth Quarter and Year-End 2013 Financial Results and Conference Call
March 04, 2014 17:45 ET
|
Onconova Therapeutics
NEWTOWN, Pa., March 4, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. to Present at the Cowen and Company 34th Annual Health Care Conference
February 26, 2014 09:02 ET
|
Onconova Therapeutics
NEWTOWN, Pa., Feb. 26, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...